Towards appreciating appropriate clinical responses to highly sensitive cardiac troponin assays

Internal Medicine Journal

Volumn 42, Issue SUPPL.5, 2012, Pages 16-22

  Bima, A ^a,b   Sikaris, K ^a  

^a Melbourne Pathology ^*  (Australia)

^b Aziz University   (Saudi Arabia)

Author keywords

Cardiac disease; Cardiac marker; Highly sensitive troponin assay; hs Tn; hs TnT; Troponin

Indexed keywords

TROPONIN I; TROPONIN T;

ARTICLE; ASSAY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; HEART INFARCTION; HEART INJURY; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REFERENCE VALUE; SENSITIVITY ANALYSIS;

AGE FACTORS; ANIMALS; BIOLOGICAL MARKERS; HEART DISEASES; HUMANS; PREDICTIVE VALUE OF TESTS; TROPONIN I; TROPONIN T;

EID: 84867200224     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2012.02893.x     Document Type: Article

References (50)

1. Apple FS. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem 2009; 55: 1303-1306.
2. Aldous SJ, Florkowski CM, Crozier IG, Elliott J, George P, Lainchbury JG etal. Comparison of high sensitivity and contemporary troponin assays for the early detection of acute myocardial infarction in the emergency department. Ann Clin Biochem 2011; 48: 241-248.
3. Lewandrowski K, Chen A, Januzzi J. Cardiac markers for myocardial infarction. Am J Clin Pathol 2002; 118: S93-99.
4. Jaffe AS, Wu AHB. Troponin release - reversible or irreversible injury? Should we care? Clin Chem 2012; 58: 148-150.
5. White HD. Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? J Am Coll Cardiol 2011; 57: 2406-2408.
6. Hickman PE, Potter JM, Aroney C, Koerbin G, Southcott E, Wu AH etal. Cardiac troponin may be released by ischemia alone, without necrosis. Clin Chim Acta 2010; 411: 318-323.
7. Yeo KTJ, Quinn-Hall KS, Bateman S, Fischer G, Wieczorek S, Wu A. Functional sensitivity of cardiac troponin assays and its implications for risk stratification for patients with acute coronary syndromes. In: Adams JE, Apple FS, Jaffe AS, Wu AHB, eds. Markers in Cardiology: Current and Future Clinical Applications. Am Heart Association Monograph Series. New York: Wiley-Blackwell; 2001; 23-30.
8. Bates KJ, Hall EM, Fahie-Wilson MN, Kindler H, Bailey C, Lythall D etal. Circulating immunoreactive cardiac troponin forms determined by gel filtration chromatography after acute myocardial infarction. Clin Chem 2010; 56: 952-958.
9. Apple FS, Collinson PO. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012; 58: 54-61.
10. Ricchiuti V, Voss EM, Ney A, Odland M, Anderson PAW, Apple FS. Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim. Clin Chem 1998; 44: 1919-1924.
11. Bodor GS, Survant L, Voss EM, Smith S, Porterfield D, Apple FS. Cardiac troponin T composition in normal and regenerating human skeletal muscle. Clin Chem 1997; 43: 476-484.
12. Jaffe AS, Vasile VC, Milone M, Saenger AK, Olson KN, Apple FS. Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T. J Am Coll Cardiol 2011; 58: 1819-1824.
13. Katus HA, Remppis A, Scheffold T, Diederich KW, Kuebler W. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol 1991; 67: 1360-1367.
14. Gaze DC, Collinson PO. Multiple molecular forms of circulating cardiac troponin: analytical and clinical significance. Ann Clin Biochem 2008; 45: 349-355.
15. Katrukha AG, Bereznikova AV, Filatov VL, Esakova TV, Kolosova OV, Pettersson K etal. Degradation of cardiac troponin I: implication for reliable immunodetection. Clin Chem 1998; 44: 2433-2440.
16. Katrukha A, Bereznikova A, Filatov V, Esakova T. Biochemical factors influencing measurement of cardiac troponin I in serum. Clin Chem Lab Med 1999; 37: 1091-1096.
17. Katrukha AG, Bereznikova AV, Esakova TV, Pettersson K, Lövgren T, Severina ME etal. Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex. Clin Chem 1997; 43: 1379-1385.
18. Cummins B, Auckland ML, Cummins P. Cardiac-specific troponin-l radioimmunoassay in the diagnosis of acute myocardial infarction. Am Heart J 1987; 113: 1333-1344.
19. Tate JR, Bunk DM, Christenson RH, Katrukha A, Noble JE, Porter RA etal. Standardisation of cardiac troponin I measurement: past and present. Pathology 2010; 42: 402-408.
20. Wu AHB, Jaffe AS. The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing. Am Heart J 2008; 155: 208-214.
21. Bima A, Lu ZX, Botros M, Sikaris KA. Age and eGFR as predictors of high sensitivity Troponin T. Clin Biochem Rev 2011; 32: S37.
22. Hammarsten O, Fu MLX, Sigurjonsdottir R, Petzold M, Said L, Landin-Wilhelmsen K etal. Troponin T percentiles from a random population sample, emergency room patients and patients with myocardial infarction. Clin Chem 2012; 58: 628-637.
23. Collinson PO, Heung YM, Gaze D, Boa F, Senior R, Christenson R etal. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem 2012; 58: 219-225.
24. La'ulu SL, Roberts WL. Performance characteristics of five cardiac troponin I assays. Clin Chim Acta 2010; 411: 1095-1101.
25. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction: the Joint European Society of Cardiology/American College of Cardiology Committee. J Am Coll Cardiol 2000; 36: 959-969.
26. Group ACSGW. Guidelines for the management of acute coronary syndromes 2006. Med J Aust 2006; 184: S1-S32.
27. Chew DP, Aroney CN, Aylward PE, Kelly AM, White HD, Tideman PA etal. Addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes (ACS) 2006. Heart Lung Circ 2011; 20: 487-502.
28. White HD. Will new higher-precision troponins lead to clarity or confusion? Curr Opin Cardiol 2008; 23: 292-295.
29. Giannitsis E, Becker M, Kurz K, Hess G, Zdunek D, Katus HA. High-sensitivity cardiac Troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin Chem 2010; 56: 642-650.
30. Melanson SEF, Morrow DA, Jarolim P. Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. Am J Clin Pathol 2007; 128: 282-286.
31. Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E etal. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009; 361: 868-877.
32. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S etal. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009; 361: 858-867.
33. White HD. Higher sensitivity troponin levels in the community: what do they mean and how will the diagnosis of myocardial infarction be made? Am Heart J 2010; 159: 933-936.
34. Thygesen K, Alpert JS, White HD, Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 2007; 28: 2525-2538.
35. Apple FS, Pearce LA, Smith SW, Kaczmarek JM, Murakami MAM. Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events. Clin Chem 2009; 55: 930-937.
36. Wu AHB, Lu QA, Todd J, Moecks J, Wians F. Short-and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice. Clin Chem 2009; 55: 52-58.
37. Eggers KM, Lagerqvist B, Venge P, Wallentin L, Lindahl B. Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality. Circulation 2007; 116: 1907-1914.
38. Zethelius B, Johnston N, Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men. Circulation 2006; 113: 1071-1078.
39. Omland T, de Lemos JA, Sabatine MS, Christophi CA, Murguia Rice M, Jablonski KA etal. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009; 361: 2538-2547.
40. Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, vonScheidt W. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol 2001; 38: 1934-1941.
41. Ilva T, Lassus J, Siirilä-Waris K, Peuhkurinen K, Pulkki K, Nieminen MS etal. Clinical significance of cardiac troponins I and T in acute heart failure. Eur J Heart Fail 2008; 10: 772-779.
42. Alehagen U, Dahlström U, Rehfeld JF, Goetze JP. Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements. Clin Chem 2010; 56: 1718-1724.
43. Wallace TW, Abdullah SM, Drazner MH, Das SR, Khera A, McGuire DK etal. Prevalence and determinants of troponin T elevation in the general population. Circulation 2006; 113: 1958-1965.
44. Hallén J, Johansen OE, Birkeland KI, Gullestad L, Aakhus S, Endresen K etal. Determinants and prognostic implications of cardiac troponin T measured by a sensitive assay in type 2 diabetes mellitus. Cardiovasc Diabetol 2010; 9: 52.
45. Fernandes CJ Jr, Akamine N, Knobel E. Myocardial depression in sepsis. Shock 2008; 30: 14-17.
46. Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM etal. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984; 100: 483-490.
47. Kristien M, Spapen HD, Nguyen DN, Garbar C, Huyghens LP, Gorus FK. Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem 2000; 46: 650-657.
48. Fernandes C Jr, Akamine N, Knobel E. Cardiac troponin: a new serum marker of myocardial injury in sepsis. Intensive Care Med 1999; 25: 1165-1168.
49. Yucel T, Memiş D, Karamanlioglu B, Süt N, Yuksel M. The prognostic value of atrial and brain natriuretic peptides, troponin I and C-reactive protein in patients with sepsis. Exp Clin Cardiol 2008; 13: 183-188.
50. Røsjø H, Varpula M, Hagve TA, Karlsson S, Ruokonen E, Pettilä V etal. Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome. Intensive Care Med 2011; 37: 77-85.